Search results for "Dysfibrinogenemia"

showing 2 items of 2 documents

Clinical disorders responsible for plasma hyperviscosity and skin complications

2017

In this brief review, we have examined some clinical disorders which are associated to an altered hemorheological profile and at times accompanied by skin ulcers. This skin condition may be, in fact, observed in patients with primary plasma hyperviscosity such as multiple myeloma, Waldenstrom macroglobulinemia, cryoglobulinemia, cryofibrinogenemia, dysfibrinogenemia and connective tissue diseases. It must be underlined that the altered hemorheological pattern is not the only responsible for this skin complication but, as it worsens the microcirculatory flow, it contributes to determine the occurrence of the skin ulcers.

Pathologymedicine.medical_specialtyParaproteinemiasCryofibrinogenemiaHyperviscosityConnective tissuePlasma hyperviscosity030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesWhole-blood viscositySkin UlcerInternal MedicinemedicineHumansDysfibrinogenemiaConnective Tissue DiseasesMultiple myeloma030203 arthritis & rheumatologyintegumentary systembusiness.industryMicrocirculationDisease ManagementWaldenstrom macroglobulinemiaSyndromeBlood Viscositymedicine.diseaseCryoglobulinemiaDermatologymedicine.anatomical_structureCryoglobulinemiaWaldenstrom MacroglobulinemiaMultiple MyelomaComplicationbusinessEuropean Journal of Internal Medicine
researchProduct

Haemorheological profile in congenital afibrinogenemia and in congenital dysfibrinogenemia: A clinical case report

2019

Although the inherited quantitative and qualitative disorders of fibrinogen are rare, in the course of time patients may develop complications including episodes of arterial and venous thrombosis. It can be useful to complete the laboratory assessment of these clinical conditions with the evaluation of the haemorheological profile. The data obtained from this study showed that congenital afibrinogenemia was characterized by a primary plasma hypoviscosity, whereas congenital dysfibrinogenemia by a primary plasma hyperviscosity. Both these haemorheological alterations may concur, with different mechanisms, to the pathogenesis of thrombotic vascular complications.

AdultMaleHypoviscosityPediatricsmedicine.medical_specialtyPhysiologyHyperviscosity030204 cardiovascular system & hematologyFibrinogen030218 nuclear medicine & medical imagingYoung Adult03 medical and health sciences0302 clinical medicinePhysiology (medical)medicineHumansAfibrinogenemiabusiness.industryCongenital dysfibrinogenemiaFibrinogenHematologyMiddle AgedAfibrinogenemiamedicine.diseaseCongenital afibrinogenemiaVenous thrombosisFemaleClinical caseCardiology and Cardiovascular MedicinebusinessHumanmedicine.drugClinical Hemorheology and Microcirculation
researchProduct